Health IT

Healthcare information (HIT) systems are designed to connect all the elements together for patient data, reports, medical imaging, billing, electronic medical record (EMR), hospital information system (HIS), PACS, cardiology information systems (CVIS)enterprise image systemsartificial intelligence (AI) applications, analytics, patient monitors, remote monitoring systems, inventory management, the hospital internet of things (IOT), cloud or onsite archive/storage, and cybersecurity.

NIH-Funded Study Shows Improved EHR Usability and 2.5 X Efficiency with Dictation and Structured Data Extraction vs. Conventional Keyboard and Mouse Entry

ZyDoc, a New York-based medical informatics company, reported results from its Phase I SBIR research study sponsored by the National Institutes of Health, with additional funding by NYSTAR, regarding alternative EHR data entry with dictation. James M. Maisel, M.D., Chairman of ZyDoc served as the Principal Investigator for the project, entitled “Applying NLP to Free Text as an EHR Data Capture Method to Improve EHR Usability.” The approved scientific study awarded to ZyDoc was performed with Columbia University physicians and compared the documentation quality, efficiency, and user satisfaction of conventional data entry in their Allscripts EHR to an alternative method allowing physicians to dictate representative admitting documents for three specialties. The alternative method (“NLP entry”) generated transcribed documents from dictations that were processed using natural language processing (NLP) to extract standard structured ICD-9, ICD-10, SNOMED®, RxNorm and LOINC® terms that are the basis of the next generation of EHR systems being implemented in October 2014.

Thumbnail

HITRUST, HHS to offer monthly cyber threat briefings

Starting next month, health industry consortium HITRUST and the Department of Health & Human Services will conduct monthly cyber threat briefings to help organizations better understand current and probable cyber threats and share best practices for cyber threat defense and response.

Thumbnail

Onward with Stage 3

Once again, Meaningful Use is the big news this week. This time, the news is that the federal Health IT Policy Committee voted to approve the Meaningful Use Work Group’s Stage 3 recommendations.

Study: HIE use correlated with 30% drop in readmissions, cost savings

Health information exchange usage directly correlated to significant cost savings and a 30 percent reduction in readmissions through the emergency department, according to a study published in Applied Clinical Informatics.

Thumbnail

HITPC advances Stage 3 recommendations

Meaningful Use has been top of mind for most in healthcare with Stage 2 requirements presenting numerous hurdles for eligible hospitals and professionals.

Thumbnail

Report: Fewer data breaches, but greater ability to control costs

While the number of data breaches decreased slightly during the past year, healthcare organizations have improved their ability to control data breach costs, according to the Ponemon Institute's “Fourth Annual Benchmark Study on Patient Privacy & Data Security,” which was funded by ID Experts.

Thumbnail

HITPC: ONC Workforce Development Program led to employment gains

The Office of the National Coordinator for Health IT’s (ONC’s) Workforce Development Program trained thousands of students and helped bolster their employment prospects, according an evaluation of the program presented at the Health IT Policy Committee meeting on March 11.

HIT Policy Committee approves Stage 3 recs after debate

After much debate during the March 11 Health IT Policy Committee meeting, members of the federal advisory committee voted to approve the Meaningful Use Work Group’s Stage 3 recommendations.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.